AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Dec 20, 2019
34491_dirs_2019-12-20_71de51ab-f01d-4243-a429-9c602efcb347.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-12-19
Reporting Person: Heery Christopher (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-19 | Common Stock | P | 250 | $12.09 | Acquired | 250 | Direct |
| 2019-12-19 | Common Stock | P | 2235 | $12.08 | Acquired | 2485 | Direct |
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19